Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig. 2007

Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.

BACKGROUND Cyclooxygenase (COX)-2 expression in the heart increases after myocardial infarction (MI). In murine models of MI, COX-2 inhibition preserves left ventricular dimensions and function. We studied the effect of selective COX-2 inhibition on left ventricular remodeling and function after MI in a pig model. RESULTS Twenty-two pigs were assigned to COX-2 inhibition with a COX-2 inhibitor (COX-2i; celecoxib 400 mg twice daily; n=14) or a control group (n=8). MI was induced by left circumflex coronary artery ligation, and the animals were euthanized 6 weeks later. Cardiac dimensions and function were assessed with echocardiography and conductance catheters. Infarct size and collagen density were analyzed with triphenyltetrazolium chloride staining and picrosirius red staining, respectively. COX-2 inhibition increased mortality compared with controls (50% versus 0%, P=0.022), whereas infarct size was similar (13.1+/-0.7% versus 14.1+/-0.1%, P=0.536). The decrease in thickness of the infarcted myocardial wall was more pronounced in the COX-2i group (60.6+/-9.6% versus 36.2+/-5.7%, P=0.001). End-diastolic volume was higher in the COX-2i group (133.9+/-33.5 versus 91.1+/-24.0 mL; P=0.021), as was the end-systolic volume at 100 mm Hg (81.7+/-27.8 versus 56.3+/-21.1 mL; P=0.037), which indicates that systolic function was more severely impaired. Infarct collagen density was lower after COX-2i treatment (25.3+/-3.9 versus 56.1+/-23.8 gray value/mm2; P=0.005). CONCLUSIONS In pigs, COX-2 inhibition after MI is associated with increased mortality, enhanced left ventricular remodeling, and impaired systolic function, probably due to decreased infarct collagen fiber density.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000068579 Celecoxib A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,Celebrex,SC 58635,SC-58635,SC58635
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
December 2010, Journal of echocardiography,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
November 1995, Cardiologia (Rome, Italy),
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
May 1992, Archives des maladies du coeur et des vaisseaux,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
July 2021, Circulation,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
September 2008, Basic research in cardiology,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
December 1997, The American journal of physiology,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
May 1986, European heart journal,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
May 2003, Circulation,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
January 1995, Annual review of medicine,
Leo Timmers, and Joost P G Sluijter, and Cees W J Verlaan, and Paul Steendijk, and Maarten Jan Cramer, and Maringa Emons, and Chaylendra Strijder, and Paul F Gründeman, and Siu Kwan Sze, and Lin Hua, and Jan J Piek, and Cornelius Borst, and Gerard Pasterkamp, and Dominique P V de Kleijn
May 2003, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!